COVID-19大流行期间破裂腹主动脉瘤急诊手术管理
本研究回顾性比较11个血管中心2020年1-3月与2018、2019年同期收治的破裂腹主动脉瘤(rAAA)患者的围手术期流程与结局。2020年采用围手术期流程加速新冠病毒检测并避免术前延误,结合交叉感染预防策略,结果显示疫情期间手术结局不劣于既往年份,院内死亡率分别为2018年37.5%、2019年25.0%、2020年14.3%。
要点
- 疫情期间采用围手术期流程可加速新冠病毒检测并避免术前延误。
- 2020年85.7%的rAAA患者接受EVAR优先策略,与2018、2019年相似。
- 疫情期间手术结局不劣于2018、2019年,院内死亡率2020年14.3%。
核心结论
- 疫情期间针对rAAA的急诊管理及感染预防经验有效优化了急诊手术结局。
研究设计与样本
- 回顾性比较11个血管中心2020年1-3月与2018、2019年同期收治的rAAA患者数据。
主要发现
- 2018、2019、2020年1-3月分别收治8例、12例、14例rAAA患者。
- 2020年85.7%的rAAA患者接受EVAR优先策略,与2018、2019年相似。
- 2020年平均ICU停留1.8±3.4天,趋于短于2018、2019年,住院时间三年相似。
- 2018、2019、2020年院内死亡率分别为37.5%、25.0%、14.3%。
- 3例急诊手术患者疑似COVID-19,术后检测均为阴性。
临床怎么用
- 疫情期间对rAAA患者应用围手术期流程加速新冠病毒检测并避免术前延误。
- 结合交叉感染预防策略保障医护人员安全。
- EVAR优先策略在疫情期间可维持与既往相似的治疗比例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a global pandemic which may compromise the management of vascular emergencies. An uncompromised treatment for ruptured abdominal aortic aneurysm (rAAA) during such a health crisis represents a challenge. This study aimed to demonstrate the treatment outcomes of rAAA and the perioperative prevention of cross-infection under the COVID-19 pandemic. METHODS: In cases of rAAA during the pandemic, a perioperative workflow was applied to expedite coronavirus testing and avoid pre-operative delay, combined with a strategy for preventing cross-infection. Data of rAAA treated in 11 vascular centers between January-March 2020 collected retrospectively were compared to the corresponding period in 2018 and 2019. RESULTS: Eight, 12, and 14 rAAA patients were treated in 11 centers in January-March 2018, 2019, and 2020, respectively. An increased portion were treated at local hospitals with a comparable outcome compared with large centers in Guangzhou. With EVAR-first strategy, 85.7% patients with rAAA in 2020 underwent endovascular repair, similar to that in 2018 and 2019. The surgical outcomes during the pandemic were not inferior to that in 2018 and 2019. The average length of ICU stay was 1.8 ± 3.4 days in 2020, tending to be shorter than that in 2018 and 2019, whereas the length of hospital stay was similar among 3 years. The in-hospital mortality of 2018, 2019, and 2020 was 37.5%, 25.0%, and 14.3%, respectively. Three patients undergoing emergent surgeries were suspected of COVID-19, though turned out to be negative after surgery. CONCLUSIONS: Our experience for emergency management of rAAA and infection prevention for healthcare providers is effective in optimizing emergent surgical outcomes during the COVID-19 pandemic.
引用
- Li Z, Qi M, Zhao G, et al. Managing Emergent Surgery for Ruptured Abdominal Aortic Aneurysm during the COVID-19 Pandemic. Ann Vasc Surg. 2021. PMID: 34644628. doi:10.1016/j.avsg.2021.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。